Portfolio AOP Health
Product overview with focus on integrated therapies for rare diseases and in critical care.
Product Overview
AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.
Ambrisentan AOP
Ambrisentan AOP is used to treat adult patients with pulmonary arterial hypertension (PAH) functional class II and III including combination therapy.
Tadalalfil AOP
Tadalafil AOP is used to treat adults with pulmonary arterial hypertension (PAH) to improve exercise capacity (the ability to carry out physical activity).
Trisuva®
Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) for improving exercise capacity and alleviate disease symptoms in patients with New York Heart Association (NYHA) Functional Class III.